CIK 0001971532 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Telomir Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TELO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- FL
- Entity type
- operating
- EIN
- 872606031
- Phone
- 786-396-6723
- Business address
- 100 SE 2ND ST, SUITE 2000 #1009, MIAMI, FL, 33131
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-21 | Aminov Erez CEO and Chairman | Grant or award · Incentive Stock Options (right to buy) | +1,960,170 | 1,960,170 | ||
| 2026-05-21 | Aminov Erez CEO and Chairman | Returned to the company · Incentive Stock Options (right to buy) | −1,960,170 | 0 | ||
| 2026-05-21 | Aminov Erez CEO and Chairman | Grant or award · Non-Qualified Stock Options (right to buy) | +2,000,000 | 2,000,000 | ||
| 2026-05-21 | Aminov Erez CEO and Chairman | Returned to the company · Non-Qualified Stock Options (right to buy) | −2,000,000 | 0 | ||
| 2026-05-21 | Whalen Matthew Pratt Director | Grant or award · Incentive Stock Options (right to buy) | +25,000 | 25,000 | ||
| 2026-05-21 | Whalen Matthew Pratt Director | Returned to the company · Incentive Stock Options (right to buy) | −25,000 | 0 | ||
| 2026-05-21 | MacPherson Edward Clouston Director | Grant or award · Incentive Stock Options (right to buy) | +25,000 | 25,000 | ||
| 2026-05-21 | MacPherson Edward Clouston Director | Returned to the company · Incentive Stock Options (right to buy) | −25,000 | 0 | ||
| 2026-05-21 | Del Giudice Matthew Paul Director | Grant or award · Incentive Stock Options (right to buy) | +25,000 | 25,000 | ||
| 2026-05-21 | Del Giudice Matthew Paul Director | Returned to the company · Incentive Stock Options (right to buy) | −25,000 | 0 | ||
| 2026-04-22 | Aminov Erez CEO and Chairman | Other acquisition | +7,319,710 | $1.37 | $10.0M | 7,319,710 |
| 2026-04-16 | Whalen Matthew Pratt Director | Grant or award · Non-Qualified Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2026-04-16 | Del Giudice Matthew Paul Director | Grant or award · Non-Qualified Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2026-04-16 | MacPherson Edward Clouston Director | Grant or award · Non-Qualified Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2025-05-28 | Aminov Erez CEO and Chairman | Grant or award · Non-Qualified Options | +2,000,000 | 2,000,000 | ||
| 2025-05-28 | Aminov Erez CEO and Chairman | Grant or award · Restricted Stock Units (RSUs) | +400,000 | 400,000 | ||
| 2024-11-21 | Bay Shore Trust 10% owner | Gift · Common Stock (right to buy) | −100,000 | 2,339,025 | ||
| 2024-08-27 | Yanez Michelle Chief Financial Officer | Grant or award · Incentive Stock Options (right to buy) | +200,000 | 200,000 | ||
| 2024-08-27 | Jerman Michael Allen Director | Grant or award · Incentive Stock Options (right to buy) | +25,000 | 25,000 | ||
| 2024-08-27 | MacPherson Edward Clouston Director | Grant or award · Incentive Stock Options (right to buy) | +25,000 | 25,000 |
Page 1 of 2 · 26 trades